SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-08-172215
Filing Date
2008-08-11
Accepted
2008-08-08 18:24:45
Documents
7
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 663888
2 GILEAD SCIENCES, INC. 2004 EQUITY INCENTIVE PLAN dex1059.htm EX-10.59 98362
3 GILEAD SCIENCES, INC. SEVERANCE PLAN dex1060.htm EX-10.60 211626
4 OFFER LETTER DATED APRIL 16, 2008 dex1061.htm EX-10.61 24188
5 CEO CERTIFICATION, AS REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) dex311.htm EX-31.1 7943
6 CFO CERTIFICATION, AS REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) dex312.htm EX-31.2 7964
7 CEO & CFO CERTIFICATIONS, AS REQUIRED BY RULE 13A-14(B) OR RULE 15D-14(B) dex32.htm EX-32 4311
  Complete submission text file 0001193125-08-172215.txt   1019678
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filer) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19731 | Film No.: 081003930
SIC: 2836 Biological Products, (No Diagnostic Substances)